Table 1.
Tumor growth and CTL induction after transfer of MC-GP cell suspension or tumor pieces in C57BL/6 or ALY × ALY mice
Transferred cells, dose | Recipient | Tumor growth*
|
CTL priming†
|
||
---|---|---|---|---|---|
Growing | Tumor free | Growing tumors, CTL+/total tested | No tumors, CTL+/total tested | ||
MC-GP (2 × 106) Cell suspension | C57BL/6 | 0 | 30 | Not testable | 15/15 |
MC-GP (2–5 × 106) Tumor piece | C57BL/6 | 119 | 41 | 0/22 | 10/15‡ |
MC-GP (107) Cell suspension | ALY × ALY | 6 | 0 | 0/6 | Not testable |
MC-GP (2–5 × 106) Tumor piece | ALY × ALY | 6 | 0 | 0/6 | Not testable |
Tumor size was followed for 4 weeks or longer. Tumors reaching a volume of 1 cm3 or more were counted as growing tumors.
CTL activity was determined at day 8 after injection of cell suspensions or 4 weeks after transplantation of solid tumor pieces after in vitro stimulation with GP33-41-pulsed splenocytes during 5 days; the numbers shown represent number of mice responding with secondary CTLs (CTL+) over total number of mice tested in each category.
Five transplanted tumor pieces did not grow because of transplantation failure, depending on the quality of the transplanted tumor pieces.